Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:56:56.594Z.
Calculation as of: 2026-10-06T18:56:56.594Z.
Quote observation: 2026-10-06T18:53:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8e2f3ec51e074b036058196f7f903a3cac1545bb57f25a27b7ce4fd0c255fbf9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Galectin Therapeutics Inc.
Market Cap
$243.01M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.31M
Price/FCF Ratio
N/A
TTM Avg
780.39
3Y Avg
474.08
5Y Avg
244.04
Market Cap
$238.81M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$245.36M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.66M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | $243.01M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | N/A | 780.39 | 474.08 | 244.04 |
| Q32 Bio Inc. (QTTB)vs › | $242.58M | N/A | 8.17 | 8.17 | 8.17 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $238.81M | N/A | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $245.36M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $246.29M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | 20.72 | 18.26 | 16.59 | 17.78 |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.66M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.36M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $236.58M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
